background: Gap junctions (GJs) allow for direct communication between adjacent cells. They are composed of connexons consisting of transmembrane proteins, connexins (Cxs). The objectives of this study were to determine if GJ proteins GJA1 (Cx43), GJB1 (Cx32) and GJB2 (Cx26) are present in the epididymis of men with a normal epididymis, to assess whether or not Cx expression and localization are altered in azoospermic patients, and to determine if epidermal growth factor (EGF) regulates GJA1 expression.
Introduction
Spermatozoa are formed by spermatogenesis in seminiferous tubules of the testis. In mammals, testicular spermatozoa do not have the ability to swim or fertilize. These functions are acquired in the epididymis during sperm maturation (Orgebin-Crist, 1969) . Anatomically, epididymides are paired organs located adjacent to each testis. Testicular input is conveyed via the efferent ducts which anastomose to form the single convoluted epididymal duct (Robaire and Hermo, 1988) . In the human, the epididymis is subdivided both morphologically and physiologically into three segments: the head (caput), body (corpus) and tail (cauda) (Yeung et al., 1991) . Epididymal epithelial cells that line the lumen of the tubule are responsible for modulating the segmentspecific luminal environment necessary for sperm maturation (Cornwall et al., 1990; Hermo and Robaire, 2002; Robaire et al., 2006) . Several studies have shown that epididymal functions can be regulated by testicular and lumicrine factors (reviewed in Robaire et al., 2006) . While androgens are known to be major regulators of epididymal functions, non-androgenic testicular factors also play a role in the regulation of several genes (Turner et al., 2007) . Epidermal growth factor (EGF) has been proposed as an important regulator of epididymal function (Tomsig et al., 2006) , and endogenous EGF-like activity has been reported in the human epididymis (Elson et al., 1984) . In addition, the EGF receptor (EGFR, also known as HER1) is expressed in the epididymis of non-human primates and of the boar (Radhakrishnan and Suarez-Quian, 1992; Oliva-Hernandez and Perez-Gutierrez, 2008) . Tsutsumi et al. (1986) reported that the removal of the submaxillary gland in the mouse, an organ rich in EGF, resulted in a decrease in epididymal sperm counts, and that this was reversible upon administration of EGF. However, subsequent studies by Russell et al. (1990) observed less dramatic effects of EGF on the testis and epididymis.
Intercellular co-ordination of complex epithelia, such as the epididymis, is mediated via gap junctions (GJs) Dufresne et al., 2003; Cyr, 2011) . Epididymal GJs were first identified by freeze fracture electron microscopy at the apical and lateral margins of principal cells (Friend and Gilula, 1972) . GJs form transmembrane channels between adjacent cells, permitting bidirectional communication between cells via the selective passage of small molecules (,1 kDa), including secondary messengers (Goodenough, 1978) . GJs are formed from a family of twenty different connexin (Cx) proteins named according to their molecular mass. Cx subunits oligomerize to form hemichannels or connexons (Beyer et al., 1990) . In the rat epididymis, GJA1 (also known as Cx43) is localized between principal and basal cells (Cyr et al., 1996) . Other Cxs, such as GJA1, GJB1 (also known as Cx32) and GJB2 (also known as Cx26), have been shown to be differentially expressed during post-natal epididymal development . In the testis, GJA1 has been shown to be critical for the differentiation of Sertoli cells and the post-natal initiation of spermatogenesis (Sridharan et al., 2007) . While the expression of Cxs during post-natal development in the epididymis suggests a similar role in principal cell differentiation, this remains to be demonstrated Cyr, 2011) . At the moment there are no reports on the presence or regulation of Cxs in the human epididymis.
Several regulators of Cxs have been reported in the male reproductive tract. Androgens, estrogens and thyroid hormones have all been shown to be important for the expression and cellular targeting of Cxs (Cyr et al., 1996; Habermann et al., 2001; St-Pierre et al., 2003; Gilleron et al., 2006 Gilleron et al., , 2009 Lydka et al., 2011) . Using orchidectomized rats in which the epididymis is regressed and stimulating the epididymis with dihydrotestosterone, Hamzeh and Robaire (2010) showed that Cx31 is androgen dependent and their analyses predicted that epididymal Cx43 is regulated by EGF and insulin-like growth factor (IGF) via endothelin1 and the IGF-binding protein 3. In other tissues, EGF has been shown to regulate the expression and the phosphorylation of GJ proteins, such as GJA1, directly or indirectly by activation of a cascade of kinases, including extracellular regulated kinase (ERK)1/2 and phosphoinositide-3-kinase (PI3K) (Warn-Cramer et al., 1998; Bolamba et al., 2002; Abdelmohsen et al., 2007; Park et al., 2007) . Whether or not EGF is an important regulator of Cxs in the human male reproductive tract is not known.
Several studies have demonstrated that during cellular distress, related to disease or chemical insult, the expression and localization of Cxs are altered, resulting in abnormal intercellular communication (reviewed in Mesnil et al., 2005) . Loss of intercellular communication between certain cells within an epithelium may represent a defense mechanism of the epithelium, by limiting communication between distressed and healthy cells (Kandouz and Batist, 2010) . Loss of gap junctional intercellular communication is a hallmark of a precancerous state and can be induced by several factors, including environmental pollutants that act via intracellular signaling pathways, such as PI3K/ AKT (Plante et al., 2002 (Plante et al., , 2006 .
Male infertility is caused by several factors but in over half of cases the cause is idiopathic (de Kretser, 1997; Seshagiri, 2001) . Azoospermia, a lack of sperm in the ejaculate, can result from an obstruction in the male reproductive tract (obstructive azoospermia, OA) or testicular failure (non-obstructive azoospermia, NOA) (Patrizo and Amin, 2002) . It has been reported that testicular GJA1 mRNA levels are significantly reduced in azoospermic patients (Defamie et al., 2003) . Patients afflicted by these types of infertility provide valuable models for investigating cellular and molecular regulation of human epididymal function. In NOA, most testicular factors that regulate epididymal parameters are still present in the lumen with the exception of spermatozoa, whereas in OA both lumicrine testicular factors and spermatozoa are absent downstream of the blockage. Previous studies have shown that tight junctional proteins are altered in azoospermic men (Dube et al., 2008) and that cell lines derived from infertile men with OA lack the ability to express a multitude of tight and adherens junction proteins (Dube et al., 2010) . To date, however, there is no information regarding the consequences of azoospermia on GJs in the epididymis.
The objectives of the present study were to investigate the expression of different Cxs (GJA1, GJB1, GJB2) and EGFR along the human epididymis of fertile and infertile men, determine the localization of GJA1 and EGFR, and assess the regulation of GJA1 by EGF in the human epididymis using a human caput epididymal cell line (Dube et al., 2010) .
Materials and Methods

Tissue preparation
Human epididymides were obtained from patients with active spermatogenesis and proved fertility (group 1) undergoing radical orchidectomy for localized testicular cancer (confined within the testicular tunica albuginea with no sign of epididymal lesion or obstruction). For the infertile patients, tissues of the epididymal tubule were obtained from patients with NOA (group 2) undergoing microsurgical sperm extraction surgery, and from patients with OA (group 3) undergoing vasoepididymostomy. All subjects with NOA have a histological confirmation of Sertoli-cell only syndrome. All subjects with OA have a histological confirmation of normal spermatogenesis. In both cases, small pieces of epididymis were obtained microsurgically when they were opened to allow the tubular fluid to be examined microscopically for the presence of sperm. Description of the patients is given in Table I . Each patient gave their informed consent and the protocols were approved by McGill University Ethics Committee. For group 3 patients, a piece of epididymis was taken distal and adjacent to the obstruction site. Tissues were excised, placed immediately in cold culture medium with antibiotics and processed within 1 h after surgery.
Real-time RT -PCR
Frozen tissue from each segment of the epididymis (caput, corpus and cauda; see schematic in Dube et al., 2007) was ground in liquid nitrogen, homogenized in lysis buffer and RNA was extracted using the Illustra Mini Isolation Kit (GE Healthcare, Baie d'Urfé, QC, Canada) according to the manufacturer's instructions. Total RNA (500 ng) was reverse transcribed using an Oligo (dT) 16 primer (R&D Systems, Minneapolis, MN, USA). Real-time RT -PCR was performed as previously described (Dube et al., 2008) using the PerfeCTa TM SYBR Green SuperMix (Quanta Biosciences Inc., Gaithersburg, MD, USA). Primers were designed with Oligo Primer Analyses Software (Molecular Biology Insights, Cascade, CO, USA) based on sequences available in GenBank (National Center for Biotechnology Information, Bethesda, MD, USA). GJA1 was amplified using genespecific forward (5 ′ GCA GGC GGG AAG CAC CAT CT) and reverse (5 ′ CTG CTG CTG GCA CGA CT GCT) primers with an expected amplicon of 159 bp (Tm 608C). The primers for GJB1 (forward primer 5 ′ ACA CCT TGC TCA GTG GCG TGA and reverse primer 5 ′ AGG GAC CAC AGC CGC ACA TGG) amplified a predicted amplicon of 217 bp (Tm 58.58C) while the primers used for GJB2 (forward primer 5 ′ CGC AGA GCA AAC CGC CCA GA and reverse primer 5 ′ AGC CTG GCT GCA GGG TGT TG) had an expected amplicon of 205 bp (Tm 608C). EGFR was amplified using gene-specific primers (Tm 608C; forward primer 5 ′ CTGCAGTGGGCAACCCCGAG and reverse primer 5 ′ TGCTTTGTGGCGCGACCCTT) and resulted in the amplification of the predicted 222 bp product. ACTB was used as a housekeeping gene (Tm 548C; forward primer 5 ′ TCT GTG TGG ATT GGT GGC TCT A and reverse primer 5 ′ CTG CTT GCT GAT CCA CAT CTG) yielding an amplification product of 69 bp that was used to normalize Cxs and EGFR mRNA levels. Melting curves were obtained to ensure the specificity of PCR amplifications.
Immunocytochemistry
Immunocytochemistry was carried out as previously described (Dube et al., 2007) using a rabbit polyclonal anti-GJA1 (0.2 mg/ml; cat#sc9059; Santa Cruz Biotechnology, Santa Cruz, CA, USA) and a rabbit monoclonal anti-EGFR (0.28 mg/ml; cat#4267; Cell Signaling, Danvers, MA, USA). Primary antibodies were incubated with deparaffinized epididymal sections (5 mm) for 1 h at room temperature following heat-induced epitope retrieval with citrate buffer and blocking for 30 min at 378C. Tris-buffered saline (TBS; 20 mM Tris-HCl, 500 mM NaCl, pH 7.5) and serum in lieu of the primary antibodies were used as negative controls. Antibody binding was detected using a biotinylated anti-rabbit secondary antibody (3 mg/ ml; Vector Laboratories, Burlingame, CA, USA) incubated for 1 h at room temperature. The Catalyzed Signal Amplification System (Dako, Carpenteria, CA, USA) was used for further amplification, according to the manufacturer's instructions.
Cell culture and EGF stimulation
Human caput epididymal cells (FHCE1; Dube et al., 2010) were grown on 35 mm petri dishes coated with mouse collagen IV (5 mg/cm 2 ; BD Biosciences, Mississauga, ON, Canada) in Dulbecco's modified Eagle's medium/HAM F12 culture medium containing antibiotics and nutrients at 328C in a humidified chamber with 5% CO 2 (Dube et al., 2010) Once the cells reached 95% confluence, they were washed with phosphate-buffered saline (PBS) and placed in serum and EGF-free culture medium for 24 h. The cells were then stimulated with EGF (50 ng/ml; Sigma-Aldrich, Mississauga). Total proteins were extracted at different time-points after the start of EGF treatment.
Specific inhibitors of protein kinase MEK1/2 (U0126; 10 mM, Cell Signaling), and PI3K (LY294002; 50 mM; Cell Signaling) were used to inhibit these respective pathways. For these experiments, FHCE1 cells were washed with PBS and incubated for 1 h with either 0.1% dimethylsulphoxide (DMSO, control vehicle) or with the appropriate inhibitor (diluted from stock solutions in DMSO) diluted in serum and EGF-free medium prior to EGF stimulation (50 ng/ml). The PI3K inhibitor was also present in the medium for the duration of the EGF stimulation. Each experiment was repeated thrice.
Western blot
Cells were lysed in cold RIPA buffer [PBS, 1% IGEPAL, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS)] supplemented with 100 mg/ ml phenylmethylsulfonyl fluoride (Sigma-Aldrich), 100 mM sodium orthovanadate (Sigma-Aldrich), a protease inhibitor cocktail (Sigma-Aldrich) and a phosphatase inhibitor cocktail (PhosStop 1X, Roche, Laval, QC, Canada). Lysates were agitated at 48C for 30 min, briefly sonicated and centrifuged at 10 000g for 10 min at 48C to remove cellular debris. Prior to electrophoresis, total protein concentrations were determined in supernatants using the Bradford reagent (Sigma-Aldrich) according to the manufacturer's instructions. Proteins (40 mg) were diluted in Laemmli loading buffer, heated at 958C for 5 min, and separated by SDS -polyacrylamide gel electrophoresis (PAGE; 25 mM Tris, 192 mM Glycine, 0.1% SDS pH 8.3). For GJA1 detection, 8% PAGE was used while 12% PAGE was used for GJB1. Proteins were then transferred for 1 h at 400 mA in transfer buffer [25 mM Tris, 192 mM Glycine, 0.1% SDS, 20% (v/v) methanol pH 8.3] onto a nitrocellulose membrane (Bio-Rad Laboratories, Mississauga, ON, Canada). A solution of Ponceau red S (0.6% Ponceau, 1% acetic acid) was used to stain the membrane for proteins and assess the efficiency of the transfer. Membranes were blocked for 1 h at room temperature with 5% non-fat dry milk diluted in TBS containing 0.1% Tween-20 (TBST, Fisher Scientific, Ottawa, ON, Canada). The membranes were subsequently incubated overnight at 48C with primary antibodies diluted in TBST containing 5% bovine serum albumin (BSA, Fisher Scientific). The primary antibodies used were: rabbit polyclonal anti-GJA1 (0.2 mg/ml; cat#sc9059; Santa Cruz Biotechnology); rabbit polyclonal anti-phospho-GJA1 (0.2 mg/ml; cat#sc12900-R; Santa Cruz Biotechnology); rabbit polyclonal anti-GJB1 (1.0 mg/ml; cat#C3470; Sigma); rabbit monoclonal anti-EGFR (0.014 mg/ml; cat#4267; Cell Signaling); rabbit monoclonal antiphospho-EGFR (Tyr1068, 0.174 mg/ml; cat#3777; Cell Signaling); rabbit monoclonal anti-AKT (0.031 mg/ml; cat#4691; Cell Signaling); rabbit monoclonal anti-phospho-AKT (Ser473, 0.075 mg/ml; cat#4060; Cell Signaling); rabbit polyclonal anti-ERK1/2 (0.0104 mg/ml; cat#9102; Cell Signaling); and rabbit polyclonal anti-phospho-ERK1/2 (Thr202/Tyr 204, 0.0246 mg/ml; cat#9101; Cell Signaling). Membranes were washed thrice in TBST for 5 min and probed with an anti-rabbit horse-radish peroxidase (HRP)-conjugated secondary antibody (0.045 mg/ml, #7074, Cell Signaling or 0.08 mg/ml, #sc2004, Santa Cruz Biotechnology for GJA1, phospho-GJA1 and GJB1). Membranes were subsequently washed as described above and visualized with Lumilight Western Blotting Substrate (Roche). Protein levels were normalized against ACTB with a mouse monoclonal anti-ACTB antibody (0.5 mg/ml; cat#A4700; Sigma) incubated for 1 h at room temperature and revealed with an anti-mouse HRP-conjugated secondary antibody (0.133 mg/ml; cat#sc2005; Santa Cruz Biotechnology). Quantification was performed with the Quantity One Software (Bio-Rad Laboratories).
Immunofluorescence FHCE1 cells were grown as described above on Permanox Lab-Tek chamber slides (Nalge Nunc International, Rochester, NY, USA). After being placed in serum and EGF-free culture medium for 24 h, cells were washed with PBS and incubated for 1 h with either 0.1% DMSO (control vehicle) or with the PI3K-specific inhibitor LY294002 (diluted from stock solutions in DMSO) diluted in serum and EGF-free medium prior to a 24 h EGF stimulation (50 ng/ml). The inhibitor was present in the medium for the duration of the EGF stimulation. Cells were fixed with methanol containing 20% (v/v) acetone at 48C for 10 min, washed twice with PBS and then blocked for 1 h at room temperature in PBS containing 2% BSA. Cells were incubated for 1 h at room temperature with a rabbit polyclonal anti-GJA1 antibody (1.28 mg/ml; cat#C6219; Sigma) diluted in blocking solution. Cells were washed thrice in PBS for 5 min and then incubated for 1 h at room temperature with a goat anti-rabbit Alexa Fluor 488 conjugated secondary antibody (0.045 mg/ml, cat#A11008, Life Technologies Inc., Burlington, ON, Canada). Cells were washed again thrice with PBS and mounted with Vectashield mounting medium containing propidium iodide (Vector Laboratories). Slides were visualized using a confocal microscope. Immunostaining without primary antibody was used as a negative control.
Statistics
Data are presented as the mean + SEM. Statistical analyses were performed using either a t-test or a one-way analysis of variance (ANOVA) when appropriate (significance was set at P , 0.05). Statistical tests were carried out using the GraphPad Prism software (ver. 5.01; LaJolla, CA, USA).
Results
GJA1, GJB1, GJB2 and EGFR mRNA in the epididymis of fertile and infertile azoospermic patients
Segment-specific expression of GJA1, GJB1, GJB2 and EGFR mRNA was determined by real-time RT -PCR in the caput, corpus and cauda epididymidis of three group 1 patients, three group 2 patients and four group 3 patients (Fig. 1A ). There were no significant differences in GJA1 mRNA levels in the different segments of the epididymis Figure 1 Steady-state mRNA levels of GJ proteins A1 (GJA1), B1
(GJB1), B2 (GJB2) and EGFR along the human epididymis of group 1, 2 and 3 patients. Relative mRNA levels of GJA1 (A), GJB1 (B), GJB2 (C) and EGFR (D) as determined by real-time RT-PCR using tissue samples of group 1 (n ¼ 3), group 2 (n ¼ 3), group 3a patients (cauda; n ¼ 3) and group 3b patients (corpus; n ¼ 1). Results are expressed as a ratio of mRNA levels of each target gene normalized to actin (ACTB) (mean + SEM; *P , 0.05 ANOVA).
of group 1 patients (Fig. 1A) , nor were there any differences in the levels of GJA1 in the caput and corpus epididymidis of group 2 patients (Fig. 1A) . However, in the cauda epididymidis of both group 2 and group 3a patients, and in the corpus epididymidis of the group 3b patient, the expression levels of GJA1 were significantly reduced when compared with levels in group 1 patients (Fig. 1A ). There were no significant differences in GJB1 mRNA levels in the different segments of the epididymis of group 1 patients (Fig. 1B) , nor were there any differences in the levels of GJB1 in the caput and corpus epididymidis of group 2 patients (Fig. 1B) . However, in the cauda epididymidis of both group 2 and 3a patients and in the corpus epididymidis of the group 3b patient, the expression levels of GJB1 were significantly reduced when compared with levels in fertile patients (Fig. 1B) , an expression pattern similar to that observed for GJA1. GJB2 mRNA levels were similar in the different segments of the epididymis of group 1 patients (Fig. 1C) . The expression levels of GJB2 did not change in any of the epididymal segments of NOA and OA patients when compared with group 1 patients (Fig. 1C) .
EGFR mRNA levels were similar along the different segments of the epididymis of group 1 patients (Fig. 1D) . EGFR mRNA levels were not significantly different in the caput corpus and cauda epididymidis between group 1 and 2 patients (Fig. 1D) . However, in group 3 patients, the expression of EGFR was lower in the corpus and significantly lower in the cauda epididymidis downstream of the obstruction when compared with approximately the same region in group 1 patients (Fig. 1D) .
Immunolocalization of GJA1 and EGFR in the epididymis of fertile and infertile azoospermic patients GJA1 was localized by immunohistochemistry at the interface between basal and principal cells in all three epididymal segments of group 1 patients (corpus shown in Fig. 2A) . A weak immunoreaction was also observed along the lateral plasma membranes of principal cells (arrowheads; Fig. 2A ). In group 2 patients, there appeared to be an increase in the cytoplasmic localization of GJA1 when compared with that of group 1 patients (Fig. 2B) . In group 3 patients, a strong immunoreaction was observed in the cytoplasm of both principal and basal cells for GJA1 when compared with both group 1 and group 2 patients (Fig. 2C) . No immunoreaction was observed in sections incubated without primary antiserum (Fig. 2D) .
As with GJA1, in the epididymis of group 1 patients, EGFR was localized along the plasma membrane of epithelial cells in between principal cells and in between principal and basal cells (Fig. 2E) . In both group 2 and 3 patients, there was a strong cytoplasmic immunoreaction for EGFR in basal cells and a slightly less intense cytoplasmic reaction in principal cells (Fig. 2F and G) . No immunoreaction was observed in sections incubated in absence of primary antiserum (Fig. 2H) .
EGF-induced activation of EKR1/2 and AKT
Since EGFR and GJA1 were both decreased in group 3 patients, we wanted to determine whether or not EGFR signaling pathways may be responsible for the decrease in the levels of GJA1 in the epididymis. We examined both the ERK1/2 and PI3K pathways which have been shown to be regulated by EGF in other cell types (Warn-Cramer et al., 1998; Bolamba et al., 2002; Abdelmohsen et al., 2007; Park et al., 2007) . Human caput epididymal FHCE1 cells were cultured with EGF for up to 30 min. The results indicate that levels of phosphorylated EGFR, ERK1/2 and the PI3K target AKT were induced when FHCE1 cells were stimulated with 50 ng/ml of EGF (Fig. 3A) . For all three proteins, a significant stimulation was observed within 5 min of adding EGF and remained elevated for 30 min. Treatment of EGFstimulated cells with the MEK1/2 inhibitor U0126 did not, as expected, alter pEGFR expression levels (Fig. 3B) but significantly decreased the ratio of pERK1/2 to ERK1/2 after 5 min. This effect was abolished after 30 min (Fig. 3B) . Treatment of EGF-stimulated cells with the PI3K inhibitor LY294002 also did not alter the phosphorylated EGFR levels (Fig. 3C) but significantly decreased the phosphorylated levels of the PI3K target AKT at both 5 and 30 min (Fig. 3C) .
EGF-induced phosphorylation of GJA1
To assess the role of EGFR signaling on GJA1 phosphorylation, FHCE1 cells were cultured with EGF alone, or EGF with either the MEK1/2 (U0126) or PI3K (LY294002) inhibitors. The results indicate that in EGF-stimulated cells, the phosphorylated GJA1 (pGJA1) was induced in a time-dependent manner (Fig. 4A) . In cells treated the MEK1/2 inhibitor (U0126) there was a significant decrease in pGJA1 at both 5 and 30 min (Fig. 4B) . Treatment of EGF-stimulated cells with the PI3K inhibitor (LY294002) did not result in any significant effect on pGJA1 levels, although there was a tendency for lower levels at 30 min (Fig. 4C) .
To further examine the role of PI3K/AKT signaling on GJA1, we examined the effects of LY294002 inhibitor for 24 h. The results indicated that EGF stimulation increased total GJA1 levels in FHCE1 cells and this was significantly inhibited by of the treatment with the inhibitor (Fig. 5A ). GJB1 protein levels were not affected by the treatment (Fig. 5B) . GJA1 localization by immunofluorescence indicated that GJA1 was localized at the cell-cell contacts of FHCE1 cells (Fig. 6A) . However, in cells treated with LY294002 for 24 h, there was an absence of GJA1 immunofluorescence along the plasma membrane and the reaction was present throughout the cytoplasm (Fig. 6B) . No fluorescence was observed in cells incubated with primary antiserum (Fig. 6C) .
Discussion
The role of GJs in male reproductive function has gained increasing attention over the past decade. In the testis, GJA1 between Sertoli cells appears to be critical for thyroid hormone-induced Sertoli cell differentiation and spermatogenesis (St-Pierre et al., 2003; Brehm et al., 2007; Sridharan et al., 2007) . In the rat epididymis, the expression of GJB2 during post-natal development suggests that it may play a similar role in epithelial cell differentiation as does GJA1 in Sertoli cells . In the present study, we have shown that gap junctional intercellular communication in the human epididymis involves GJA1, GJB1 and GJB2. GJA1 was immunolocalized between basal and principal cells, similar to its previously reported localization in the rat epididymis (Cyr et al., 1996; Dufresne et al., 2003) . In addition, GJA1 was also observed along the lateral margins of adjacent principal cells, where GJs have previously been shown to be present (Cyr et al., 1995) .
The presence of a variety of different Cxs suggests that multiple signals may be exchanged between adjacent cells. Cxs are known to form selective pores, or connexons, that allow molecules of different size or charge to pass between neighboring cells (Nicholson et al., 2000; Goldberg et al., 2004) . This selectivity may be important for coordinating the passage of regulatory molecules between both homologous and heterologous cell types in the epididymal epithelium (Hermo and Robaire, 2002) . As in the rat, the levels of GJB2 in the adult human epididymis were low relative to other Cxs . Previous studies have reported that in the rat GJB2 may play an important Figure 2 GJA1 and EGFR localization in the human corpus epididymidis of group 1, 2 and 3 patients. Immunolocalization of GJA1 (A -D) and EGFR (E -H) in the human corpus epididymidis of group 1, 2 and 3b patients. Distinct staining (brown in color) is observed (arrowheads) in the presence of antibody in tissues of group 1 patients (a, e) as well as in group 2 (NOA) patients (b, f) and in group 3 (OA) patients (c, g). In epididymides from both the group 2 and 3 patients, there was an increase in the cytoplasmic localization of both EGFR and GJA1 in basal and principal cells. Similar results were also observed in the cauda epididymidis. No signal was detected in the negative controls (d, h). Original magnification ×1008. Lu, lumen; It, interstitium; B, basal cell; P, principal cell. role in early post-natal development and cellular differentiation of epididymal epithelial cells . Whether or not this is also the case in the human epididymis is unknown.
There were several differences in the expression and/or localization of Cxs in the epididymis of patients in the different groups. The fact that the expression of GJA1 and GJB1 was decreased in both group 2 and 3 patients suggest that these Cxs are regulated, at least in part, by lumicrine factors of testicular or epididymal origin or this may be related to the absence of spermatozoa in the epididymal lumen. In group 2 patients, the reduced expression could be related to alterations in testicular secretions since epididymal cells in these patients are exposed to luminal factors. Interestingly, Defamie et al. (2003) also reported a decrease in GJA1 in the testis of azoospermic infertile patients. Since the effects observed in the epididymis were only observed in the cauda for GJA1 and GJB1, we cannot discount the possibility that epididymal factors from the caput epididymidis may also play a role in the regulation of GJA1. Epididymal gene expression varies between the segments of the epididymis suggesting that, as stimulated with EGF (50 ng/ml) for 0, 5 or 30 min and analyzed by western blotting for phosphorylation of EGFR, ERK1/2 and AKT. EGFR, ERK-1/2 and AKT were, respectively, used for normalization. (B) The MEK-1/2 inhibitor U0126 (10 mM) was present 1 h prior to EGF treatment. DMSO (0.1%) served as control in samples without inhibitor. Phosphorylation of EGFR, ERK1/2 and AKT was determined by western blot and, respectively, normalized to EGFR, ERK1/2 and AKT. (C) The PI3K inhibitor LY294002 (50 mM) was present 1 h prior to and for the duration of EGF treatment (50 ng/ml). DMSO (0.1%) served as control in samples without inhibitor. Phosphorylated EGFR, ERK1/2 and AKT were determined by western blot and normalized to EGFR, ERK1/2 and AKT, respectively. Data are presented relative to time 0 min controls. Each value represents the mean + SEM of three experiments. (*P , 0.05, **P , 0.01, ***P , 0.001 ANOVA).
in rodents, there is segment-specific regulation of gene expression (Dube et al., 2007; Dubé and Cyr, 2012) . Several growth factors, such as EGF, fibroblast growth factor and vascular endothelial growth factor are expressed, and presumably secreted, in the proximal region of the epididymis, and these may regulate epididymal Cxs (Tomsig et al., 2006) . In group 3 patients, the cells do not receive luminal input because of the obstruction. Therefore, the decrease in GJA1, GJB1 and EGFR in the cauda epididymidis is likely to result exclusively from the absence of stimulatory luminal factors, as these cells would still receive testicular input from the circulation. The mRNA levels for each of the GJA1, GJB1 and EGFR genes, as well as for GJB2, were decreased in the corpus, which unfortunately is based on a single patient, reflecting the difficulty in obtaining these tissues. Several studies have shown that testicular factors, such as androgens, are present at much higher concentrations in the epididymal lumen than in circulation, and that these high hormone levels are necessary to regulate gene expression in the epididymis Sipila et al., 2006) . The decrease in Cxs indicates that intercellular communication is likely negatively altered in azoospermic patients. It has recently been reported that in mice where a mutation was induced in Cx43m while the morphology of the epididymis was not consistently altered, there was a decrease in several sperm motility parameters that are generally associated with epididymal sperm maturation (Gregory et al., 2011) . of the phosphorylation (P1, P2 phosphorylated forms) and expression of GJA1 (P1, P2 phosphorylated forms and P0 non-phosphorylated form) was evaluated by western blotting and normalized to ACTB (mean + SEM, n ¼ 3). (B) Cells were incubated with the inhibitor U0126 (10 mM) for 1 h and stimulated with EGF (50 ng/ml) for 0 -30 min. The level of GJA1 phosphorylation (P1, P2 phosphorylated forms) and expression of GJA1 (P1/P2 phosphorylated forms and P0 non-phosphorylated form) was examined by Western blotting and normalized to ACTB (mean + SEM, n ¼ 3). (C) Cells were incubated with the inhibitor LY294002 (50 mM) for 1 h prior to and for the duration of EGF stimulation (50 ng/ml) for 0 -30 min. The levels of phosphorylated (P1, P2 forms) and total GJA1 (P0, P1 and P2 forms) was determined by western blotting and normalized to ACTB (mean + SEM, n ¼ 3). Data are presented relative to time 0 min controls. Each value represents the mean + SEM of three experiments. Representative blots of each experiment are shown (*P , 0.05, **P , 0.01, ***P , 0.001 ANOVA).
Whether or not lower Cx43 in human epididymis can alter cell-cell communication in the epididymis or epididymal function is not known.
In the mouse, it has been suggested that EGF is present in the epididymis in a segment-specific manner with higher levels in the corpus and cauda epididymidis (Tomsig et al., 2006) . A previous study in our laboratory, using microarrays, demonstrated that EGF was detected in the human epididymis of 2-4 group 1 type patients, depending on the region, with a tendency for lower levels in the corpus epididymides Figure 5 Effect of EGF on GJA1 and GJB1 levels. (A) FHCE1 cells were incubated in the presence of EGF (50 ng/ml) for 0 -24 h. FHCE1 cells were incubated with the inhibitor LY294002 (50 mM) for 1 h prior to and for the duration of EGF stimulation (50 ng/ml). After 0, 2 and 24 h, the level of total GJA1 protein (P0, P1 and P2 forms) was examined by western blotting and normalized to ACTB (mean + SEM, n ¼ 3). (B) Cells were incubated in the presence of EGF (50 ng/ml) for 0 -24 h. FHCE1 cells were incubated with the inhibitor LY294002 (50 mM) for 1 h prior to and for the duration of EGF stimulation (50 ng/ml). GJA1 and GJB1 levels were measured at 0 and 24 h by western blotting and analysis. Densitometric scans of each Cx were quantified and normalized to ACTB (mean + SEM, n ¼ 3). Data are presented relative to time 0 min controls. Each value represents the mean + SEM of three replicates from three separate experiments (*P , 0.05 ANOVA). when compared with other regions (Accession number GSE23812 on http://www.ncbi.nlm.nih.gov/geo/). In addition, as with the current study for the EGFR mRNA levels, EGF mRNA levels are similar in caput epididymides of group 1 and group 2 patients (Accession number GSE9194 on http://www.ncbi.nlm.nih.gov/geo/). Given the small amount of tissue obtained at surgery, it was not possible to measure EGF protein levels in the epididymis of these patients. The fact that we observed a decrease in EGFR in the single group 3b patient with a blockage in the caput as well as those OA patients with obstruction in the corpus epididymidis, suggests that decreased EGFR signaling may contribute to decreased Cx levels. Interestingly, the mRNA levels of EGFR were only reduced in group 3 patients and not in group 2 patients. The localization of both GJA1 and the EGFR was altered in azoospermic patients (group 2) where there was an increase in cytoplasmic localization in both principal and basal cells. This effect appeared more intense in OA patients. Aberrant cytoplasmic localization of Cxs has been reported in several studies associated with the occurrence of physiological distress (Defamie et al., 2001; Olbina and Eckhart, 2003) or carcinogenesis (Jee et al., 2011) . While the reason for the cytoplasmic localization of these two proteins is unknown, previous studies have shown that the cellular localization of certain claudins, a family of tight junction proteins, was also altered in group 2 patients (Dube et al., 2008) . Whether or not this cytoplasmic localization is related to changes associated with the tight junction protein ZO-1, which can bind to the cytoplamic domains of both Cx43 and claudins, or if the change in claudin localization is linked to the loss of GJs, as it has been suggested in the testis (Carette et al., 2010; Li et al., 2010) , is currently unknown. Clearly, however, Cx43 GJs in the epididymis are negatively affected in azoospermic patients.
While steady-state mRNA levels for EGFR and Cx43 were decreased in group 2 and 3 patients, the immunoreaction appeared somewhat more intense in these patients. Whether this is reflective of increased protein levels or simply the result of post-transcriptional events is not known at the moment and because of limited tissue this could not be addressed using more quantitative methodology.
It has been suggested that phosphorylation of GJA1 has an effect on its trafficking and the assembly of GJs (Lampe and Lau, 2004) . Our results show that, in FHCE1 cells, EGF regulates GJA1 phosphorylation. In addition, we have demonstrated that EGF-induced phosphorylation of GJA1 occurs via ERK1/2 pathway. It is possible that in human epididymal principal cells, as in human kidney cells, EGF induces phosphorylation of GJA1 and increases GJIC through a protein synthesis-dependent mechanism (Vikhamar et al., 1998) . Given some of the similarities between the development of the kidney and the epididymis, it is possible that Cxs in these tissues may be regulated in a similar fashion.
EGF increased the levels of GJA1 in FHCE1 cells after 24 h via the PI3K/AKT pathway. It has been shown that this pathway was responsible for the maintenance of GJA1 expression level in osteoblasts (Bhattacharjee et al., 2009 ). In addition, it has also been reported, in human kidney cells, that an EGF-induced increase in intercellular communication is mediated through translational control of GJA1 expression (Rivedal et al., 1996) . Thus, a deregulation of EGF signaling pathway may be responsible for the mis-targeting of GJA1 protein and alterations in GJIC. In any case, the loss of EGFR and EGF signaling in the corpus and cauda epididymidis of group 3 patients may lead to reduced GJA1 levels resulting from decreased AKT activity and therefore less GJA1 available for cell-cell communication. Either scenario would result in decreased GJA1-mediated gap junctional communication.
Interestingly, unlike GJA1, GJB1 was not regulated via the EGF signaling pathway, nor was it regulated by AKT. We have previously shown that the nuclear translocation of p-AKT can result in downregulation of GJB1 in hepatocytes (Plante et al., 2006) . Clearly, the regulation of GJB1 in human epididymal cells is different and may involve other signaling pathways, which may be deregulated in group 2 patients. The deregulation of the EGFR pathway in the epididymis could be due to the absence of EGF and other testicular factors in the epididymal lumen of group 3 patients. It has been shown that androgens increase EGF binding sites in the rat prostate (Traish and Wotiz, 1987) . In addition, it is currently unknown if epididymal epithelial cells are capable of synthesizing EGF. However, EGF is present in the testes of different species, including humans, where it is mainly produced by Leydig cells (Yan et al., 1998) . The obstruction in group 3 patients may prevent EGF from entering the epididymis and regulating epididymal functions.
Understanding the precise role and regulation of each Cx in epididymal homeostasis will provide valuable information as to how this epithelium contributes to the specific luminal microenvironment necessary for the creation of fertilizing-competent spermatozoa. Furthermore, these data support the notion that epididymal function is altered in azoospermic patients and need to be taken into consideration in developing strategies aimed at resolving male infertility.
